Presentation is loading. Please wait.

Presentation is loading. Please wait.

Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B

Published byΚλείτος Δημαράς Modified over 5 years ago

Similar presentations

Presentation on theme: "Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B"— Presentation transcript:

1 Axillofemoral bypass: Outcome and hemodynamic results in high-risk patients 
Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B. Walsh, MD, Robert M. Zwolak, MD, PhD, Jack L. Cronenwett, MD  Journal of Vascular Surgery  Volume 15, Issue 6, Pages (June 1992) DOI: / (92)90451-D Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

2 Fig. 1 Life-table patient survival after AxFB and AoFB. Number of patients entering next interval alive is indicated at each time point for both groups. Error bars indicate standard error of the mean (SEM). Survival line is broken when the SEM exceeds 10%. The difference is highly significant (log rank p < 0.001). Journal of Vascular Surgery  , DOI: ( / (92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

3 Fig. 2 Life-table primary, (a) and secondary (b) patency after AxFB and AoFB. Number of patients entering the next interval alive with a patent graft is indicated at each time point for both groups. Error bars indicate standard error of the mean (SEM). Survival line is broken when the SEM exceeds 10%. AxFB is significantly inferior to AoFB in both primary, (p = 0.032) and secondary patency (p < 0.001). Journal of Vascular Surgery  , DOI: ( / (92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

4 Fig. 3 Life-table primary patency after axillounifemoral and axillobifemoral bypass. Number of patients entering the next interval alive with a patent graft is indicated at each time point for both groups. Error bars indicate standard error of the mean (SEM). Survival line is broken when the SEM exceeds 10%. No significant difference exists between axillounifemoral and axillobifemoral primary patency (p = 0.484). Journal of Vascular Surgery  , DOI: ( / (92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

5 Fig. 4 Linear regression analysis of postoperative ABI versus femoral outflow score; (a) for the side of an axillofemoral graft limb only, (b) for any revascularized leg after axillounifemoral or axillobifemoral bypass, (c) any revascularized leg after AoFB. Journal of Vascular Surgery  , DOI: ( / (92)90451-D) Copyright © 1992 Society for Vascular Surgery and the North American Chapter, International Society for Cardiovascular Surgery Terms and Conditions

Download ppt "Joseph R. Schneider, MD, PhD, Martha D. McDaniel, MD, Daniel B"

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,
A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,

A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease  Ramon Berguer, MD, PhD, Mark D. Morasch,
Is long vein bypass from groin to ankle a durable procedure

Is long vein bypass from groin to ankle a durable procedure
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 

Lloyd M. Taylor, M.D., Edward S. Phinney, M.D., John M. Porter, M.D. 
Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results  Joseph R. Schneider, MD, PhD, Daniel B. Walsh,

Pedal bypass versus tibial bypass with autogenous vein: A comparison of outcome and hemodynamic results  Joseph R. Schneider, MD, PhD, Daniel B. Walsh,
Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,

Descending thoracic aorta to iliofemoral artery bypass grafting: A role for primary revascularization for aortoiliac occlusive disease?  Marc A. Passman,
Richard R. Proia, MD, Daniel B. Walsh, MD, Peter R. Nelson, MD, John P

Richard R. Proia, MD, Daniel B. Walsh, MD, Peter R. Nelson, MD, John P
A new valvulotome for in situ bypass grafts

A new valvulotome for in situ bypass grafts
Enrique Criado, MD, Steven J. Burnham, MD, Ellis A

Enrique Criado, MD, Steven J. Burnham, MD, Ellis A
Axillofemoral bypass: A tool with a limited role

Axillofemoral bypass: A tool with a limited role
Malcolm O. Perry, MD, Richard Kempczinski, MD 

Malcolm O. Perry, MD, Richard Kempczinski, MD 
Durability of the in situ saphenous vein arterial bypass: A comparison of primary and secondary patency  Dennis F. Bandyk, M.D., Hermann W. Kaebnick,

Durability of the in situ saphenous vein arterial bypass: A comparison of primary and secondary patency  Dennis F. Bandyk, M.D., Hermann W. Kaebnick,
Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency  William A. Marston, MD, Robert.

Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency  William A. Marston, MD, Robert.
Andrea Mingoli, MD, Paolo Sapienza, MD, Richard J

Andrea Mingoli, MD, Paolo Sapienza, MD, Richard J
Mesenteric stenting for chronic mesenteric ischemia

Mesenteric stenting for chronic mesenteric ischemia
Return to well-being and function after infrainguinal revascularization  Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,

Return to well-being and function after infrainguinal revascularization  Gary W. Gibbons, MD, Anne M. Burgess, RN, Edward Guadagnoli, PhD, Frank B. Pomposelli,
Cost-effectiveness of carotid endarterectomy in asymptomatic patients

Cost-effectiveness of carotid endarterectomy in asymptomatic patients
Vein graft lesions: Time of onset and rate of progression

Vein graft lesions: Time of onset and rate of progression
Axillopopliteal bypass for limb salvage

Axillopopliteal bypass for limb salvage

Similar presentations

Ads by Google